Prostate Cancer Models

Prostate cancer PDO models available including castration-resistant (CRPC) subtypes.

PDO 1.0 & 2.0

H&E, IHC (PSA, AR), WES

Validated Applications:

  • Androgen receptor pathway studies
  • PARP inhibitor sensitivity (HRR-deficient tumors)